Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US Supply Chain Partners Get Details On Designing Information Security Systems

Executive Summary

In draft guidance on evolving drug product tracking program, the US FDA gives thumbs-up on distributed or semi-distributed architecture for data security; support for aggregation and inference; a one-minute bar for verification.

You may also be interested in...



Lack Of Readiness In Responding To DSCSA Verification Requests Major Concern

Roughly half of all pharmaceutical manufacturers have misgivings they will have the necessary systems to electronically verify saleable returns under DSCSA, even though they must respond to these requests within 24 hours.

PIC/S Wants To Know: What About ‘Authorized Persons’ For Batch Release Outside The EU?

International association of pharmaceutical inspectorates launches industry consultation on aligning with the one EU GMP provision it spurned years ago.

Memo To File: How US FDA Decided Which Janssen Vaccine Drug Substance Batches Were OK To Use

Two batches were authorized because they were made before production waste jammed Emergent BioSolutions' Bayview plant.

Topics

UsernamePublicRestriction

Register

PS144421

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel